|
시장보고서
상품코드
1967829
줄기세포 어세이 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Stem Cell Assays Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
줄기세포 어세이 시장 규모는 2025년 23억 8,000만 달러에서 2034년에는 51억 7,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 9.01%로 성장할 전망입니다.
줄기세포 분석 시장은 재생의료, 신약개발, 독성시험에 대한 투자 증가에 따라 빠르게 성장하고 있습니다. 줄기세포 기반 분석은 질병 모델링, 효능 스크리닝, 안전성 프로파일링을 위한 생리적 관련성이 높은 모델을 가능하게 하고, 동물 모델에 대한 의존도를 낮춥니다. 이러한 성장은 유도만능줄기세포(iPSC) 기술, 오가노이드, 고함량 이미징의 발전으로 촉진되고 있으며, 이를 통해 연구자들은 인간과 유사한 조직과 복잡한 세포 간 상호 작용을 in vitro로 연구할 수 있게 되었습니다.
주요 촉진요인으로는 인간 반응을 예측할 수 있는 우수한 번역 모델에 대한 제약업계 수요, 규제 당국의 동물실험 대체 방법 장려, 줄기세포 분화 프로토콜의 학문적 돌파구 등이 있습니다. 줄기세포와 마이크로플루이딕스 기술, 3D 배양, 자동화 스크리닝을 결합한 플랫폼 기술은 처리량과 재현성을 향상시킵니다. 수탁 연구기관 및 생명공학 기업의 줄기세포 분석 업무의 외주화가 증가하면서 시장 서비스 및 소모품의 매출이 증가하고 있습니다.
향후 전망으로는 표준화, 분석 검증, 규제 당국의 수용이 진행됨에 따라 시장은 성숙기에 접어들 것으로 보입니다. 확대의 견인차 역할을 하는 것은 환자 유래 iPS 세포를 이용한 맞춤형 의료 응용과 표적 검증을 위한 CRISPR 유전자 편집 기술과의 통합입니다. 안전성 약리학, 재생의료 개발, 질병 모델 구축에 대한 공동연구의 상업적 기회도 확대될 것으로 예측됩니다. 분석의 재현성, 확장성, 비용 제약에 대한 대응이 산업 전반과 규제 환경에서의 보급 확대의 핵심이 될 것입니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 줄기세포 어세이 시장 : 제품별
제5장 세계의 줄기세포 어세이 시장 : 유형별
제6장 세계의 줄기세포 어세이 시장 : 용도별
제7장 세계의 줄기세포 어세이 시장 : 최종사용자별
제8장 세계의 줄기세포 어세이 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.03.24The Stem Cell Assays Market size is expected to reach USD 5.17 Billion in 2034 from USD 2.38 Billion (2025) growing at a CAGR of 9.01% during 2026-2034.
The stem cell assays market has expanded rapidly with increased investment in regenerative medicine, drug discovery, and toxicology testing. Stem cell-based assays enable physiologically relevant models for disease modeling, efficacy screening, and safety profiling, reducing reliance on animal models. Growth has been catalyzed by advances in induced pluripotent stem cell (iPSC) technologies, organoids, and high-content imaging, which allow researchers to study human-like tissues and complex cellular interactions in vitro.
Primary drivers include pharmaceutical industry demand for better translational models to predict human responses, regulatory encouragement for alternatives to animal testing, and academic breakthroughs in stem cell differentiation protocols. Platform technologies combining stem cells with microfluidics, 3D culture, and automated screening enhance throughput and reproducibility. Contract research organizations and biotech companies increasingly outsource stem-cell assay work, boosting market services and consumables revenue.
Looking forward, the market is poised for maturation as standardization, assay validation, and regulatory acceptance improve. Expansion will be driven by personalized medicine applications-using patient-derived iPSCs-and integration with CRISPR gene-editing for target validation. Commercial opportunities in safety pharmacology, regenerative-therapeutic development, and disease-modeling collaborations will grow. Addressing assay reproducibility, scalability, and cost constraints will be key to broader adoption across industry and regulatory settings.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Instruments
- Reagents & Kits
- Software
By Type
- Cell Viability & Toxicity Assays
- Cell Identification Assays
- Cell Proliferation Assays
- Cell Differentiation Assays
- Others
By Application
- Regenerative Medicine & Therapy Development
- Drug Discovery & Development
- Clinical Research
- Others
By End-User
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Others
COMPANIES PROFILED
- Thermo Fisher Scientific, Merck KGaA, GE Healthcare, BioRad Laboratories, Promega Corporation, Agilent Technologies, PerkinElmer, Lonza Group, Cell Biolabs, Stemcell Technologies, RD Systems
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL STEM CELL ASSAYS MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL STEM CELL ASSAYS MARKET: BY TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Type
- 5.2. Cell Viability & Toxicity Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cell Identification Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Cell Proliferation Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Cell Differentiation Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL STEM CELL ASSAYS MARKET: BY APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Regenerative Medicine & Therapy Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL STEM CELL ASSAYS MARKET: BY END-USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-user
- 7.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL STEM CELL ASSAYS MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Type
- 8.2.3 By Application
- 8.2.4 By End-user
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Type
- 8.3.3 By Application
- 8.3.4 By End-user
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Type
- 8.4.3 By Application
- 8.4.4 By End-user
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Type
- 8.5.3 By Application
- 8.5.4 By End-user
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Type
- 8.6.3 By Application
- 8.6.4 By End-user
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL STEM CELL ASSAYS INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific
- 10.2.2 Merck KGaA
- 10.2.3 GE Healthcare
- 10.2.4 Bio-Rad Laboratories
- 10.2.5 Promega Corporation
- 10.2.6 Agilent Technologies
- 10.2.7 PerkinElmer
- 10.2.8 Lonza Group
- 10.2.9 Cell Biolabs
- 10.2.10 Stemcell Technologies
- 10.2.11 R&D Systems
